nodes	percent_of_prediction	percent_of_DWPC	metapath
Telaprevir—ABCB1—peripheral nervous system neoplasm	0.451	1	CbGaD
Telaprevir—ABCB1—Topotecan—peripheral nervous system neoplasm	0.0487	0.167	CbGbCtD
Telaprevir—ABCB1—Alitretinoin—peripheral nervous system neoplasm	0.0487	0.167	CbGbCtD
Telaprevir—ABCB1—Dactinomycin—peripheral nervous system neoplasm	0.0338	0.116	CbGbCtD
Telaprevir—CYP3A4—Topotecan—peripheral nervous system neoplasm	0.0292	0.1	CbGbCtD
Telaprevir—CYP3A4—Tretinoin—peripheral nervous system neoplasm	0.0271	0.0931	CbGbCtD
Telaprevir—ABCB1—Vincristine—peripheral nervous system neoplasm	0.0208	0.0714	CbGbCtD
Telaprevir—ABCB1—Cisplatin—peripheral nervous system neoplasm	0.0194	0.0666	CbGbCtD
Telaprevir—ABCB1—Etoposide—peripheral nervous system neoplasm	0.0191	0.0654	CbGbCtD
Telaprevir—ABCB1—Doxorubicin—peripheral nervous system neoplasm	0.013	0.0446	CbGbCtD
Telaprevir—CYP3A4—Vincristine—peripheral nervous system neoplasm	0.0125	0.0428	CbGbCtD
Telaprevir—CYP3A4—Etoposide—peripheral nervous system neoplasm	0.0114	0.0392	CbGbCtD
Telaprevir—CYP3A4—Doxorubicin—peripheral nervous system neoplasm	0.00779	0.0267	CbGbCtD
Telaprevir—CTSK—skull—peripheral nervous system neoplasm	0.00682	0.316	CbGeAlD
Telaprevir—CTSK—forelimb—peripheral nervous system neoplasm	0.00657	0.305	CbGeAlD
Telaprevir—Boceprevir—ABCB1—peripheral nervous system neoplasm	0.00347	1	CrCbGaD
Telaprevir—CTSK—trigeminal ganglion—peripheral nervous system neoplasm	0.00174	0.0809	CbGeAlD
Telaprevir—CTSK—parotid gland—peripheral nervous system neoplasm	0.00164	0.0763	CbGeAlD
Telaprevir—CTSS—trigeminal ganglion—peripheral nervous system neoplasm	0.00153	0.0708	CbGeAlD
Telaprevir—CTSS—parotid gland—peripheral nervous system neoplasm	0.00144	0.0668	CbGeAlD
Telaprevir—CTSK—Osteoclast Signaling—IFNB1—peripheral nervous system neoplasm	0.00118	0.145	CbGpPWpGaD
Telaprevir—CMA1—ACE Inhibitor Pathway—KNG1—peripheral nervous system neoplasm	0.00117	0.143	CbGpPWpGaD
Telaprevir—CTSK—cerebellum—peripheral nervous system neoplasm	0.000761	0.0353	CbGeAlD
Telaprevir—CTSS—cerebellum—peripheral nervous system neoplasm	0.000667	0.0309	CbGeAlD
Telaprevir—Anaemia—Isotretinoin—peripheral nervous system neoplasm	0.00055	0.00245	CcSEcCtD
Telaprevir—Anaemia—Melphalan—peripheral nervous system neoplasm	0.000543	0.00242	CcSEcCtD
Telaprevir—Syncope—Isotretinoin—peripheral nervous system neoplasm	0.000534	0.00238	CcSEcCtD
Telaprevir—Syncope—Tretinoin—peripheral nervous system neoplasm	0.000534	0.00238	CcSEcCtD
Telaprevir—Erythema multiforme—Dactinomycin—peripheral nervous system neoplasm	0.000529	0.00235	CcSEcCtD
Telaprevir—Toxic epidermal necrolysis—Etoposide—peripheral nervous system neoplasm	0.000527	0.00235	CcSEcCtD
Telaprevir—Loss of consciousness—Tretinoin—peripheral nervous system neoplasm	0.000523	0.00233	CcSEcCtD
Telaprevir—Loss of consciousness—Isotretinoin—peripheral nervous system neoplasm	0.000523	0.00233	CcSEcCtD
Telaprevir—Urinary tract disorder—Alitretinoin—peripheral nervous system neoplasm	0.000512	0.00228	CcSEcCtD
Telaprevir—Oedema peripheral—Alitretinoin—peripheral nervous system neoplasm	0.000511	0.00227	CcSEcCtD
Telaprevir—Urethral disorder—Alitretinoin—peripheral nervous system neoplasm	0.000508	0.00226	CcSEcCtD
Telaprevir—Unspecified disorder of skin and subcutaneous tissue—Topotecan—peripheral nervous system neoplasm	0.000508	0.00226	CcSEcCtD
Telaprevir—Unspecified disorder of skin and subcutaneous tissue—Tretinoin—peripheral nervous system neoplasm	0.000503	0.00224	CcSEcCtD
Telaprevir—Unspecified disorder of skin and subcutaneous tissue—Isotretinoin—peripheral nervous system neoplasm	0.000503	0.00224	CcSEcCtD
Telaprevir—Rectal haemorrhage—Epirubicin—peripheral nervous system neoplasm	0.0005	0.00223	CcSEcCtD
Telaprevir—Unspecified disorder of skin and subcutaneous tissue—Melphalan—peripheral nervous system neoplasm	0.000497	0.00221	CcSEcCtD
Telaprevir—Hyperbilirubinaemia—Epirubicin—peripheral nervous system neoplasm	0.000497	0.00221	CcSEcCtD
Telaprevir—Urinary tract disorder—Vincristine—peripheral nervous system neoplasm	0.000493	0.0022	CcSEcCtD
Telaprevir—Erythema multiforme—Alitretinoin—peripheral nervous system neoplasm	0.00049	0.00218	CcSEcCtD
Telaprevir—Urethral disorder—Vincristine—peripheral nervous system neoplasm	0.00049	0.00218	CcSEcCtD
Telaprevir—Hyperuricaemia—Epirubicin—peripheral nervous system neoplasm	0.000487	0.00217	CcSEcCtD
Telaprevir—Infection—Topotecan—peripheral nervous system neoplasm	0.000487	0.00217	CcSEcCtD
Telaprevir—Eye disorder—Alitretinoin—peripheral nervous system neoplasm	0.000484	0.00216	CcSEcCtD
Telaprevir—Infection—Tretinoin—peripheral nervous system neoplasm	0.000483	0.00215	CcSEcCtD
Telaprevir—Infection—Isotretinoin—peripheral nervous system neoplasm	0.000483	0.00215	CcSEcCtD
Telaprevir—Nervous system disorder—Topotecan—peripheral nervous system neoplasm	0.00048	0.00214	CcSEcCtD
Telaprevir—Thrombocytopenia—Topotecan—peripheral nervous system neoplasm	0.00048	0.00214	CcSEcCtD
Telaprevir—Shock—Isotretinoin—peripheral nervous system neoplasm	0.000478	0.00213	CcSEcCtD
Telaprevir—Shock—Tretinoin—peripheral nervous system neoplasm	0.000478	0.00213	CcSEcCtD
Telaprevir—Nervous system disorder—Isotretinoin—peripheral nervous system neoplasm	0.000477	0.00212	CcSEcCtD
Telaprevir—Nervous system disorder—Tretinoin—peripheral nervous system neoplasm	0.000477	0.00212	CcSEcCtD
Telaprevir—Infection—Melphalan—peripheral nervous system neoplasm	0.000477	0.00212	CcSEcCtD
Telaprevir—Skin disorder—Topotecan—peripheral nervous system neoplasm	0.000476	0.00212	CcSEcCtD
Telaprevir—Thrombocytopenia—Tretinoin—peripheral nervous system neoplasm	0.000476	0.00212	CcSEcCtD
Telaprevir—Thrombocytopenia—Isotretinoin—peripheral nervous system neoplasm	0.000476	0.00212	CcSEcCtD
Telaprevir—Skin disorder—Tretinoin—peripheral nervous system neoplasm	0.000472	0.0021	CcSEcCtD
Telaprevir—Skin disorder—Isotretinoin—peripheral nervous system neoplasm	0.000472	0.0021	CcSEcCtD
Telaprevir—Thrombocytopenia—Melphalan—peripheral nervous system neoplasm	0.00047	0.00209	CcSEcCtD
Telaprevir—Skin disorder—Melphalan—peripheral nervous system neoplasm	0.000466	0.00207	CcSEcCtD
Telaprevir—Hepatobiliary disease—Cisplatin—peripheral nervous system neoplasm	0.000465	0.00207	CcSEcCtD
Telaprevir—Rectal haemorrhage—Doxorubicin—peripheral nervous system neoplasm	0.000463	0.00206	CcSEcCtD
Telaprevir—Blood uric acid increased—Epirubicin—peripheral nervous system neoplasm	0.00046	0.00205	CcSEcCtD
Telaprevir—Hyperbilirubinaemia—Doxorubicin—peripheral nervous system neoplasm	0.00046	0.00205	CcSEcCtD
Telaprevir—Malnutrition—Alitretinoin—peripheral nervous system neoplasm	0.000451	0.00201	CcSEcCtD
Telaprevir—Infestation NOS—Etoposide—peripheral nervous system neoplasm	0.000451	0.00201	CcSEcCtD
Telaprevir—Infestation—Etoposide—peripheral nervous system neoplasm	0.000451	0.00201	CcSEcCtD
Telaprevir—Hyperuricaemia—Doxorubicin—peripheral nervous system neoplasm	0.000451	0.00201	CcSEcCtD
Telaprevir—Anaemia—Dactinomycin—peripheral nervous system neoplasm	0.00045	0.002	CcSEcCtD
Telaprevir—Stevens-Johnson syndrome—Etoposide—peripheral nervous system neoplasm	0.000447	0.00199	CcSEcCtD
Telaprevir—Urinary tract disorder—Cisplatin—peripheral nervous system neoplasm	0.000436	0.00194	CcSEcCtD
Telaprevir—Urethral disorder—Cisplatin—peripheral nervous system neoplasm	0.000433	0.00193	CcSEcCtD
Telaprevir—Candida infection—Epirubicin—peripheral nervous system neoplasm	0.000431	0.00192	CcSEcCtD
Telaprevir—Hepatobiliary disease—Etoposide—peripheral nervous system neoplasm	0.000426	0.0019	CcSEcCtD
Telaprevir—Blood uric acid increased—Doxorubicin—peripheral nervous system neoplasm	0.000426	0.0019	CcSEcCtD
Telaprevir—Gastrointestinal disorder—Topotecan—peripheral nervous system neoplasm	0.000423	0.00188	CcSEcCtD
Telaprevir—Fatigue—Topotecan—peripheral nervous system neoplasm	0.000422	0.00188	CcSEcCtD
Telaprevir—Gastrointestinal disorder—Tretinoin—peripheral nervous system neoplasm	0.00042	0.00187	CcSEcCtD
Telaprevir—Gastrointestinal disorder—Isotretinoin—peripheral nervous system neoplasm	0.00042	0.00187	CcSEcCtD
Telaprevir—Fatigue—Tretinoin—peripheral nervous system neoplasm	0.000419	0.00187	CcSEcCtD
Telaprevir—Fatigue—Isotretinoin—peripheral nervous system neoplasm	0.000419	0.00187	CcSEcCtD
Telaprevir—Anaemia—Alitretinoin—peripheral nervous system neoplasm	0.000417	0.00186	CcSEcCtD
Telaprevir—Gastrointestinal disorder—Melphalan—peripheral nervous system neoplasm	0.000414	0.00184	CcSEcCtD
Telaprevir—Fatigue—Melphalan—peripheral nervous system neoplasm	0.000414	0.00184	CcSEcCtD
Telaprevir—Eye disorder—Cisplatin—peripheral nervous system neoplasm	0.000413	0.00184	CcSEcCtD
Telaprevir—Syncope—Alitretinoin—peripheral nervous system neoplasm	0.000405	0.0018	CcSEcCtD
Telaprevir—Anaemia—Vincristine—peripheral nervous system neoplasm	0.000402	0.00179	CcSEcCtD
Telaprevir—Urinary tract disorder—Etoposide—peripheral nervous system neoplasm	0.0004	0.00178	CcSEcCtD
Telaprevir—Candida infection—Doxorubicin—peripheral nervous system neoplasm	0.000399	0.00178	CcSEcCtD
Telaprevir—Urethral disorder—Etoposide—peripheral nervous system neoplasm	0.000397	0.00177	CcSEcCtD
Telaprevir—Loss of consciousness—Alitretinoin—peripheral nervous system neoplasm	0.000397	0.00177	CcSEcCtD
Telaprevir—Infection—Dactinomycin—peripheral nervous system neoplasm	0.000395	0.00176	CcSEcCtD
Telaprevir—Urticaria—Topotecan—peripheral nervous system neoplasm	0.000389	0.00173	CcSEcCtD
Telaprevir—Thrombocytopenia—Dactinomycin—peripheral nervous system neoplasm	0.000389	0.00173	CcSEcCtD
Telaprevir—Urticaria—Tretinoin—peripheral nervous system neoplasm	0.000386	0.00172	CcSEcCtD
Telaprevir—Urticaria—Isotretinoin—peripheral nervous system neoplasm	0.000386	0.00172	CcSEcCtD
Telaprevir—Malnutrition—Cisplatin—peripheral nervous system neoplasm	0.000385	0.00171	CcSEcCtD
Telaprevir—Erythema multiforme—Etoposide—peripheral nervous system neoplasm	0.000383	0.0017	CcSEcCtD
Telaprevir—Unspecified disorder of skin and subcutaneous tissue—Alitretinoin—peripheral nervous system neoplasm	0.000382	0.0017	CcSEcCtD
Telaprevir—Urticaria—Melphalan—peripheral nervous system neoplasm	0.000381	0.0017	CcSEcCtD
Telaprevir—Eye disorder—Etoposide—peripheral nervous system neoplasm	0.000378	0.00168	CcSEcCtD
Telaprevir—CMA1—Peptide hormone metabolism—BCHE—peripheral nervous system neoplasm	0.000366	0.0451	CbGpPWpGaD
Telaprevir—Infection—Alitretinoin—peripheral nervous system neoplasm	0.000366	0.00163	CcSEcCtD
Telaprevir—Eczema—Epirubicin—peripheral nervous system neoplasm	0.000365	0.00162	CcSEcCtD
Telaprevir—Shock—Alitretinoin—peripheral nervous system neoplasm	0.000362	0.00161	CcSEcCtD
Telaprevir—Nervous system disorder—Alitretinoin—peripheral nervous system neoplasm	0.000361	0.00161	CcSEcCtD
Telaprevir—Thrombocytopenia—Alitretinoin—peripheral nervous system neoplasm	0.000361	0.00161	CcSEcCtD
Telaprevir—Skin disorder—Alitretinoin—peripheral nervous system neoplasm	0.000358	0.00159	CcSEcCtD
Telaprevir—Anaemia—Cisplatin—peripheral nervous system neoplasm	0.000355	0.00158	CcSEcCtD
Telaprevir—Renal failure acute—Epirubicin—peripheral nervous system neoplasm	0.000355	0.00158	CcSEcCtD
Telaprevir—Infection—Vincristine—peripheral nervous system neoplasm	0.000353	0.00157	CcSEcCtD
Telaprevir—Asthenia—Topotecan—peripheral nervous system neoplasm	0.000352	0.00157	CcSEcCtD
Telaprevir—Asthenia—Tretinoin—peripheral nervous system neoplasm	0.000349	0.00155	CcSEcCtD
Telaprevir—Asthenia—Isotretinoin—peripheral nervous system neoplasm	0.000349	0.00155	CcSEcCtD
Telaprevir—Nervous system disorder—Vincristine—peripheral nervous system neoplasm	0.000348	0.00155	CcSEcCtD
Telaprevir—Thrombocytopenia—Vincristine—peripheral nervous system neoplasm	0.000348	0.00155	CcSEcCtD
Telaprevir—Pruritus—Topotecan—peripheral nervous system neoplasm	0.000347	0.00154	CcSEcCtD
Telaprevir—Dysgeusia—Etoposide—peripheral nervous system neoplasm	0.000345	0.00154	CcSEcCtD
Telaprevir—Asthenia—Melphalan—peripheral nervous system neoplasm	0.000344	0.00153	CcSEcCtD
Telaprevir—Pruritus—Tretinoin—peripheral nervous system neoplasm	0.000344	0.00153	CcSEcCtD
Telaprevir—Pruritus—Isotretinoin—peripheral nervous system neoplasm	0.000344	0.00153	CcSEcCtD
Telaprevir—Fatigue—Dactinomycin—peripheral nervous system neoplasm	0.000342	0.00152	CcSEcCtD
Telaprevir—Pruritus—Melphalan—peripheral nervous system neoplasm	0.000339	0.00151	CcSEcCtD
Telaprevir—Eczema—Doxorubicin—peripheral nervous system neoplasm	0.000338	0.0015	CcSEcCtD
Telaprevir—Diarrhoea—Topotecan—peripheral nervous system neoplasm	0.000335	0.00149	CcSEcCtD
Telaprevir—Diarrhoea—Isotretinoin—peripheral nervous system neoplasm	0.000333	0.00148	CcSEcCtD
Telaprevir—Diarrhoea—Tretinoin—peripheral nervous system neoplasm	0.000333	0.00148	CcSEcCtD
Telaprevir—Renal failure acute—Doxorubicin—peripheral nervous system neoplasm	0.000329	0.00146	CcSEcCtD
Telaprevir—Diarrhoea—Melphalan—peripheral nervous system neoplasm	0.000328	0.00146	CcSEcCtD
Telaprevir—Anaemia—Etoposide—peripheral nervous system neoplasm	0.000326	0.00145	CcSEcCtD
Telaprevir—Unspecified disorder of skin and subcutaneous tissue—Cisplatin—peripheral nervous system neoplasm	0.000325	0.00145	CcSEcCtD
Telaprevir—Dizziness—Topotecan—peripheral nervous system neoplasm	0.000324	0.00144	CcSEcCtD
Telaprevir—Dizziness—Tretinoin—peripheral nervous system neoplasm	0.000321	0.00143	CcSEcCtD
Telaprevir—Dizziness—Isotretinoin—peripheral nervous system neoplasm	0.000321	0.00143	CcSEcCtD
Telaprevir—Gastrointestinal disorder—Alitretinoin—peripheral nervous system neoplasm	0.000318	0.00142	CcSEcCtD
Telaprevir—Fatigue—Alitretinoin—peripheral nervous system neoplasm	0.000318	0.00141	CcSEcCtD
Telaprevir—Infection—Cisplatin—peripheral nervous system neoplasm	0.000312	0.00139	CcSEcCtD
Telaprevir—Vomiting—Topotecan—peripheral nervous system neoplasm	0.000312	0.00139	CcSEcCtD
Telaprevir—Loss of consciousness—Etoposide—peripheral nervous system neoplasm	0.00031	0.00138	CcSEcCtD
Telaprevir—Vomiting—Tretinoin—peripheral nervous system neoplasm	0.000309	0.00138	CcSEcCtD
Telaprevir—Vomiting—Isotretinoin—peripheral nervous system neoplasm	0.000309	0.00138	CcSEcCtD
Telaprevir—Rash—Topotecan—peripheral nervous system neoplasm	0.000309	0.00138	CcSEcCtD
Telaprevir—Dermatitis—Topotecan—peripheral nervous system neoplasm	0.000309	0.00137	CcSEcCtD
Telaprevir—Nervous system disorder—Cisplatin—peripheral nervous system neoplasm	0.000308	0.00137	CcSEcCtD
Telaprevir—Thrombocytopenia—Cisplatin—peripheral nervous system neoplasm	0.000307	0.00137	CcSEcCtD
Telaprevir—Blood creatinine increased—Epirubicin—peripheral nervous system neoplasm	0.000307	0.00137	CcSEcCtD
Telaprevir—Rash—Isotretinoin—peripheral nervous system neoplasm	0.000306	0.00136	CcSEcCtD
Telaprevir—Rash—Tretinoin—peripheral nervous system neoplasm	0.000306	0.00136	CcSEcCtD
Telaprevir—Gastrointestinal disorder—Vincristine—peripheral nervous system neoplasm	0.000306	0.00136	CcSEcCtD
Telaprevir—Dermatitis—Tretinoin—peripheral nervous system neoplasm	0.000306	0.00136	CcSEcCtD
Telaprevir—Dermatitis—Isotretinoin—peripheral nervous system neoplasm	0.000306	0.00136	CcSEcCtD
Telaprevir—Fatigue—Vincristine—peripheral nervous system neoplasm	0.000306	0.00136	CcSEcCtD
Telaprevir—Vomiting—Melphalan—peripheral nervous system neoplasm	0.000305	0.00136	CcSEcCtD
Telaprevir—Skin disorder—Cisplatin—peripheral nervous system neoplasm	0.000305	0.00136	CcSEcCtD
Telaprevir—Rash—Melphalan—peripheral nervous system neoplasm	0.000302	0.00135	CcSEcCtD
Telaprevir—Dermatitis—Melphalan—peripheral nervous system neoplasm	0.000302	0.00135	CcSEcCtD
Telaprevir—Hypokalaemia—Epirubicin—peripheral nervous system neoplasm	0.000298	0.00133	CcSEcCtD
Telaprevir—Unspecified disorder of skin and subcutaneous tissue—Etoposide—peripheral nervous system neoplasm	0.000298	0.00133	CcSEcCtD
Telaprevir—Toxic epidermal necrolysis—Epirubicin—peripheral nervous system neoplasm	0.000295	0.00131	CcSEcCtD
Telaprevir—Urticaria—Alitretinoin—peripheral nervous system neoplasm	0.000293	0.0013	CcSEcCtD
Telaprevir—Nausea—Topotecan—peripheral nervous system neoplasm	0.000291	0.0013	CcSEcCtD
Telaprevir—Nausea—Isotretinoin—peripheral nervous system neoplasm	0.000289	0.00129	CcSEcCtD
Telaprevir—Nausea—Tretinoin—peripheral nervous system neoplasm	0.000289	0.00129	CcSEcCtD
Telaprevir—Infection—Etoposide—peripheral nervous system neoplasm	0.000286	0.00127	CcSEcCtD
Telaprevir—Asthenia—Dactinomycin—peripheral nervous system neoplasm	0.000285	0.00127	CcSEcCtD
Telaprevir—Nausea—Melphalan—peripheral nervous system neoplasm	0.000285	0.00127	CcSEcCtD
Telaprevir—Blood creatinine increased—Doxorubicin—peripheral nervous system neoplasm	0.000284	0.00127	CcSEcCtD
Telaprevir—Thrombocytopenia—Etoposide—peripheral nervous system neoplasm	0.000282	0.00125	CcSEcCtD
Telaprevir—Eosinophilia—Epirubicin—peripheral nervous system neoplasm	0.000281	0.00125	CcSEcCtD
Telaprevir—Skin disorder—Etoposide—peripheral nervous system neoplasm	0.000279	0.00124	CcSEcCtD
Telaprevir—Hypokalaemia—Doxorubicin—peripheral nervous system neoplasm	0.000276	0.00123	CcSEcCtD
Telaprevir—Toxic epidermal necrolysis—Doxorubicin—peripheral nervous system neoplasm	0.000273	0.00122	CcSEcCtD
Telaprevir—Diarrhoea—Dactinomycin—peripheral nervous system neoplasm	0.000272	0.00121	CcSEcCtD
Telaprevir—Gastrointestinal disorder—Cisplatin—peripheral nervous system neoplasm	0.000271	0.00121	CcSEcCtD
Telaprevir—ABCB1—trigeminal ganglion—peripheral nervous system neoplasm	0.00027	0.0125	CbGeAlD
Telaprevir—Asthenia—Alitretinoin—peripheral nervous system neoplasm	0.000264	0.00118	CcSEcCtD
Telaprevir—Pruritus—Alitretinoin—peripheral nervous system neoplasm	0.000261	0.00116	CcSEcCtD
Telaprevir—Eosinophilia—Doxorubicin—peripheral nervous system neoplasm	0.00026	0.00116	CcSEcCtD
Telaprevir—Asthenia—Vincristine—peripheral nervous system neoplasm	0.000255	0.00113	CcSEcCtD
Telaprevir—Infestation NOS—Epirubicin—peripheral nervous system neoplasm	0.000253	0.00113	CcSEcCtD
Telaprevir—Infestation—Epirubicin—peripheral nervous system neoplasm	0.000253	0.00113	CcSEcCtD
Telaprevir—Vomiting—Dactinomycin—peripheral nervous system neoplasm	0.000253	0.00112	CcSEcCtD
Telaprevir—Diarrhoea—Alitretinoin—peripheral nervous system neoplasm	0.000252	0.00112	CcSEcCtD
Telaprevir—Stevens-Johnson syndrome—Epirubicin—peripheral nervous system neoplasm	0.000251	0.00112	CcSEcCtD
Telaprevir—Rash—Dactinomycin—peripheral nervous system neoplasm	0.00025	0.00112	CcSEcCtD
Telaprevir—Gastrointestinal disorder—Etoposide—peripheral nervous system neoplasm	0.000248	0.00111	CcSEcCtD
Telaprevir—Fatigue—Etoposide—peripheral nervous system neoplasm	0.000248	0.0011	CcSEcCtD
Telaprevir—Dizziness—Alitretinoin—peripheral nervous system neoplasm	0.000244	0.00108	CcSEcCtD
Telaprevir—Diarrhoea—Vincristine—peripheral nervous system neoplasm	0.000243	0.00108	CcSEcCtD
Telaprevir—Hepatobiliary disease—Epirubicin—peripheral nervous system neoplasm	0.000239	0.00106	CcSEcCtD
Telaprevir—Nausea—Dactinomycin—peripheral nervous system neoplasm	0.000236	0.00105	CcSEcCtD
Telaprevir—Dizziness—Vincristine—peripheral nervous system neoplasm	0.000235	0.00104	CcSEcCtD
Telaprevir—Vomiting—Alitretinoin—peripheral nervous system neoplasm	0.000234	0.00104	CcSEcCtD
Telaprevir—Infestation—Doxorubicin—peripheral nervous system neoplasm	0.000234	0.00104	CcSEcCtD
Telaprevir—Infestation NOS—Doxorubicin—peripheral nervous system neoplasm	0.000234	0.00104	CcSEcCtD
Telaprevir—Rash—Alitretinoin—peripheral nervous system neoplasm	0.000232	0.00103	CcSEcCtD
Telaprevir—Dermatitis—Alitretinoin—peripheral nervous system neoplasm	0.000232	0.00103	CcSEcCtD
Telaprevir—Stevens-Johnson syndrome—Doxorubicin—peripheral nervous system neoplasm	0.000232	0.00103	CcSEcCtD
Telaprevir—Urticaria—Etoposide—peripheral nervous system neoplasm	0.000228	0.00102	CcSEcCtD
Telaprevir—Vomiting—Vincristine—peripheral nervous system neoplasm	0.000226	0.001	CcSEcCtD
Telaprevir—Asthenia—Cisplatin—peripheral nervous system neoplasm	0.000225	0.001	CcSEcCtD
Telaprevir—Urinary tract disorder—Epirubicin—peripheral nervous system neoplasm	0.000224	0.000997	CcSEcCtD
Telaprevir—Rash—Vincristine—peripheral nervous system neoplasm	0.000224	0.000996	CcSEcCtD
Telaprevir—Dermatitis—Vincristine—peripheral nervous system neoplasm	0.000224	0.000995	CcSEcCtD
Telaprevir—Oedema peripheral—Epirubicin—peripheral nervous system neoplasm	0.000223	0.000995	CcSEcCtD
Telaprevir—Urethral disorder—Epirubicin—peripheral nervous system neoplasm	0.000222	0.00099	CcSEcCtD
Telaprevir—Hepatobiliary disease—Doxorubicin—peripheral nervous system neoplasm	0.000221	0.000985	CcSEcCtD
Telaprevir—Nausea—Alitretinoin—peripheral nervous system neoplasm	0.000219	0.000974	CcSEcCtD
Telaprevir—Diarrhoea—Cisplatin—peripheral nervous system neoplasm	0.000215	0.000956	CcSEcCtD
Telaprevir—Erythema multiforme—Epirubicin—peripheral nervous system neoplasm	0.000214	0.000955	CcSEcCtD
Telaprevir—Eye disorder—Epirubicin—peripheral nervous system neoplasm	0.000212	0.000944	CcSEcCtD
Telaprevir—Nausea—Vincristine—peripheral nervous system neoplasm	0.000211	0.000939	CcSEcCtD
Telaprevir—Urinary tract disorder—Doxorubicin—peripheral nervous system neoplasm	0.000207	0.000923	CcSEcCtD
Telaprevir—Oedema peripheral—Doxorubicin—peripheral nervous system neoplasm	0.000207	0.000921	CcSEcCtD
Telaprevir—Asthenia—Etoposide—peripheral nervous system neoplasm	0.000206	0.000918	CcSEcCtD
Telaprevir—Urethral disorder—Doxorubicin—peripheral nervous system neoplasm	0.000206	0.000916	CcSEcCtD
Telaprevir—Pruritus—Etoposide—peripheral nervous system neoplasm	0.000203	0.000906	CcSEcCtD
Telaprevir—Vomiting—Cisplatin—peripheral nervous system neoplasm	0.0002	0.000888	CcSEcCtD
Telaprevir—Erythema multiforme—Doxorubicin—peripheral nervous system neoplasm	0.000198	0.000884	CcSEcCtD
Telaprevir—Rash—Cisplatin—peripheral nervous system neoplasm	0.000198	0.000881	CcSEcCtD
Telaprevir—Dermatitis—Cisplatin—peripheral nervous system neoplasm	0.000198	0.00088	CcSEcCtD
Telaprevir—Malnutrition—Epirubicin—peripheral nervous system neoplasm	0.000197	0.000879	CcSEcCtD
Telaprevir—Diarrhoea—Etoposide—peripheral nervous system neoplasm	0.000197	0.000876	CcSEcCtD
Telaprevir—Eye disorder—Doxorubicin—peripheral nervous system neoplasm	0.000196	0.000873	CcSEcCtD
Telaprevir—Dysgeusia—Epirubicin—peripheral nervous system neoplasm	0.000193	0.000861	CcSEcCtD
Telaprevir—Dizziness—Etoposide—peripheral nervous system neoplasm	0.00019	0.000847	CcSEcCtD
Telaprevir—Nausea—Cisplatin—peripheral nervous system neoplasm	0.000186	0.00083	CcSEcCtD
Telaprevir—Vomiting—Etoposide—peripheral nervous system neoplasm	0.000183	0.000814	CcSEcCtD
Telaprevir—Malnutrition—Doxorubicin—peripheral nervous system neoplasm	0.000183	0.000814	CcSEcCtD
Telaprevir—Anaemia—Epirubicin—peripheral nervous system neoplasm	0.000183	0.000813	CcSEcCtD
Telaprevir—Rash—Etoposide—peripheral nervous system neoplasm	0.000181	0.000807	CcSEcCtD
Telaprevir—Dermatitis—Etoposide—peripheral nervous system neoplasm	0.000181	0.000806	CcSEcCtD
Telaprevir—Dysgeusia—Doxorubicin—peripheral nervous system neoplasm	0.000179	0.000797	CcSEcCtD
Telaprevir—CMA1—Extracellular matrix organization—NCAM1—peripheral nervous system neoplasm	0.000179	0.022	CbGpPWpGaD
Telaprevir—Syncope—Epirubicin—peripheral nervous system neoplasm	0.000177	0.000788	CcSEcCtD
Telaprevir—Loss of consciousness—Epirubicin—peripheral nervous system neoplasm	0.000174	0.000773	CcSEcCtD
Telaprevir—Nausea—Etoposide—peripheral nervous system neoplasm	0.000171	0.00076	CcSEcCtD
Telaprevir—Anaemia—Doxorubicin—peripheral nervous system neoplasm	0.000169	0.000752	CcSEcCtD
Telaprevir—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—peripheral nervous system neoplasm	0.000167	0.000743	CcSEcCtD
Telaprevir—Syncope—Doxorubicin—peripheral nervous system neoplasm	0.000164	0.00073	CcSEcCtD
Telaprevir—Loss of consciousness—Doxorubicin—peripheral nervous system neoplasm	0.000161	0.000715	CcSEcCtD
Telaprevir—Infection—Epirubicin—peripheral nervous system neoplasm	0.00016	0.000713	CcSEcCtD
Telaprevir—CTSK—Extracellular matrix organization—NCAM1—peripheral nervous system neoplasm	0.000159	0.0196	CbGpPWpGaD
Telaprevir—Shock—Epirubicin—peripheral nervous system neoplasm	0.000159	0.000706	CcSEcCtD
Telaprevir—Nervous system disorder—Epirubicin—peripheral nervous system neoplasm	0.000158	0.000704	CcSEcCtD
Telaprevir—Thrombocytopenia—Epirubicin—peripheral nervous system neoplasm	0.000158	0.000703	CcSEcCtD
Telaprevir—Skin disorder—Epirubicin—peripheral nervous system neoplasm	0.000157	0.000697	CcSEcCtD
Telaprevir—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—peripheral nervous system neoplasm	0.000154	0.000688	CcSEcCtD
Telaprevir—Infection—Doxorubicin—peripheral nervous system neoplasm	0.000148	0.00066	CcSEcCtD
Telaprevir—Shock—Doxorubicin—peripheral nervous system neoplasm	0.000147	0.000653	CcSEcCtD
Telaprevir—Nervous system disorder—Doxorubicin—peripheral nervous system neoplasm	0.000146	0.000651	CcSEcCtD
Telaprevir—Thrombocytopenia—Doxorubicin—peripheral nervous system neoplasm	0.000146	0.00065	CcSEcCtD
Telaprevir—Skin disorder—Doxorubicin—peripheral nervous system neoplasm	0.000145	0.000645	CcSEcCtD
Telaprevir—Gastrointestinal disorder—Epirubicin—peripheral nervous system neoplasm	0.000139	0.000619	CcSEcCtD
Telaprevir—Fatigue—Epirubicin—peripheral nervous system neoplasm	0.000139	0.000619	CcSEcCtD
Telaprevir—CYP3A4—Codeine and Morphine Metabolism—ABCB1—peripheral nervous system neoplasm	0.000136	0.0168	CbGpPWpGaD
Telaprevir—CMA1—Degradation of the extracellular matrix—CASP3—peripheral nervous system neoplasm	0.000135	0.0166	CbGpPWpGaD
Telaprevir—CTSK—Innate Immune System—CD55—peripheral nervous system neoplasm	0.000132	0.0163	CbGpPWpGaD
Telaprevir—CTSS—Extracellular matrix organization—NCAM1—peripheral nervous system neoplasm	0.000131	0.0161	CbGpPWpGaD
Telaprevir—CMA1—Signaling by SCF-KIT—PTPN11—peripheral nervous system neoplasm	0.00013	0.016	CbGpPWpGaD
Telaprevir—Gastrointestinal disorder—Doxorubicin—peripheral nervous system neoplasm	0.000129	0.000573	CcSEcCtD
Telaprevir—Fatigue—Doxorubicin—peripheral nervous system neoplasm	0.000129	0.000572	CcSEcCtD
Telaprevir—Urticaria—Epirubicin—peripheral nervous system neoplasm	0.000128	0.00057	CcSEcCtD
Telaprevir—ALB—FOXA2 and FOXA3 transcription factor networks—NF1—peripheral nervous system neoplasm	0.000122	0.015	CbGpPWpGaD
Telaprevir—CTSK—Degradation of the extracellular matrix—CASP3—peripheral nervous system neoplasm	0.00012	0.0148	CbGpPWpGaD
Telaprevir—Urticaria—Doxorubicin—peripheral nervous system neoplasm	0.000118	0.000527	CcSEcCtD
Telaprevir—ABCB1—cerebellum—peripheral nervous system neoplasm	0.000118	0.00545	CbGeAlD
Telaprevir—CTSK—Toll-Like Receptors Cascades—PTPN11—peripheral nervous system neoplasm	0.000116	0.0143	CbGpPWpGaD
Telaprevir—Asthenia—Epirubicin—peripheral nervous system neoplasm	0.000116	0.000515	CcSEcCtD
Telaprevir—CYP3A4—Irinotecan Pathway—BCHE—peripheral nervous system neoplasm	0.000116	0.0142	CbGpPWpGaD
Telaprevir—Pruritus—Epirubicin—peripheral nervous system neoplasm	0.000114	0.000508	CcSEcCtD
Telaprevir—Diarrhoea—Epirubicin—peripheral nervous system neoplasm	0.00011	0.000491	CcSEcCtD
Telaprevir—CTSS—Innate Immune System—CD55—peripheral nervous system neoplasm	0.000109	0.0134	CbGpPWpGaD
Telaprevir—Asthenia—Doxorubicin—peripheral nervous system neoplasm	0.000107	0.000476	CcSEcCtD
Telaprevir—Dizziness—Epirubicin—peripheral nervous system neoplasm	0.000107	0.000475	CcSEcCtD
Telaprevir—Pruritus—Doxorubicin—peripheral nervous system neoplasm	0.000106	0.00047	CcSEcCtD
Telaprevir—CMA1—Signaling by SCF-KIT—ERBB2—peripheral nervous system neoplasm	0.000103	0.0127	CbGpPWpGaD
Telaprevir—Vomiting—Epirubicin—peripheral nervous system neoplasm	0.000102	0.000456	CcSEcCtD
Telaprevir—Diarrhoea—Doxorubicin—peripheral nervous system neoplasm	0.000102	0.000454	CcSEcCtD
Telaprevir—Rash—Epirubicin—peripheral nervous system neoplasm	0.000102	0.000452	CcSEcCtD
Telaprevir—Dermatitis—Epirubicin—peripheral nervous system neoplasm	0.000102	0.000452	CcSEcCtD
Telaprevir—CTSS—Degradation of the extracellular matrix—CASP3—peripheral nervous system neoplasm	9.92e-05	0.0122	CbGpPWpGaD
Telaprevir—Dizziness—Doxorubicin—peripheral nervous system neoplasm	9.86e-05	0.000439	CcSEcCtD
Telaprevir—CTSK—Innate Immune System—PPP3R1—peripheral nervous system neoplasm	9.64e-05	0.0119	CbGpPWpGaD
Telaprevir—CTSK—Adaptive Immune System—CD34—peripheral nervous system neoplasm	9.62e-05	0.0118	CbGpPWpGaD
Telaprevir—CTSK—RANKL/RANK Signaling Pathway—AKT1—peripheral nervous system neoplasm	9.58e-05	0.0118	CbGpPWpGaD
Telaprevir—Nausea—Epirubicin—peripheral nervous system neoplasm	9.57e-05	0.000426	CcSEcCtD
Telaprevir—CTSS—Toll-Like Receptors Cascades—PTPN11—peripheral nervous system neoplasm	9.57e-05	0.0118	CbGpPWpGaD
Telaprevir—Vomiting—Doxorubicin—peripheral nervous system neoplasm	9.48e-05	0.000422	CcSEcCtD
Telaprevir—Rash—Doxorubicin—peripheral nervous system neoplasm	9.4e-05	0.000419	CcSEcCtD
Telaprevir—Dermatitis—Doxorubicin—peripheral nervous system neoplasm	9.39e-05	0.000418	CcSEcCtD
Telaprevir—Nausea—Doxorubicin—peripheral nervous system neoplasm	8.86e-05	0.000394	CcSEcCtD
Telaprevir—CTSS—Innate Immune System—PPP3R1—peripheral nervous system neoplasm	7.94e-05	0.00977	CbGpPWpGaD
Telaprevir—CTSS—Adaptive Immune System—CD34—peripheral nervous system neoplasm	7.92e-05	0.00974	CbGpPWpGaD
Telaprevir—CMA1—Signaling by SCF-KIT—NRAS—peripheral nervous system neoplasm	7.84e-05	0.00964	CbGpPWpGaD
Telaprevir—CTSK—Immune System—CD55—peripheral nervous system neoplasm	7.7e-05	0.00947	CbGpPWpGaD
Telaprevir—CYP3A4—Drug Induction of Bile Acid Pathway—ABCB1—peripheral nervous system neoplasm	7.45e-05	0.00917	CbGpPWpGaD
Telaprevir—CMA1—Metabolism of proteins—BCHE—peripheral nervous system neoplasm	6.92e-05	0.00851	CbGpPWpGaD
Telaprevir—CTSK—Innate Immune System—IFNB1—peripheral nervous system neoplasm	6.68e-05	0.00822	CbGpPWpGaD
Telaprevir—CTSS—Immune System—CD55—peripheral nervous system neoplasm	6.34e-05	0.0078	CbGpPWpGaD
Telaprevir—CTSK—Immune System—CD34—peripheral nervous system neoplasm	5.83e-05	0.00718	CbGpPWpGaD
Telaprevir—CMA1—Signaling Pathways—NTS—peripheral nervous system neoplasm	5.82e-05	0.00716	CbGpPWpGaD
Telaprevir—CMA1—Signaling by SCF-KIT—HRAS—peripheral nervous system neoplasm	5.73e-05	0.00705	CbGpPWpGaD
Telaprevir—CMA1—Extracellular matrix organization—CASP3—peripheral nervous system neoplasm	5.66e-05	0.00697	CbGpPWpGaD
Telaprevir—CTSK—Immune System—PPP3R1—peripheral nervous system neoplasm	5.61e-05	0.00691	CbGpPWpGaD
Telaprevir—CMA1—Signaling Pathways—CD55—peripheral nervous system neoplasm	5.58e-05	0.00687	CbGpPWpGaD
Telaprevir—CTSS—Innate Immune System—IFNB1—peripheral nervous system neoplasm	5.5e-05	0.00677	CbGpPWpGaD
Telaprevir—ABCB1—HIF-1-alpha transcription factor network—SLC2A1—peripheral nervous system neoplasm	5.18e-05	0.00637	CbGpPWpGaD
Telaprevir—CMA1—Signaling by SCF-KIT—AKT1—peripheral nervous system neoplasm	5.06e-05	0.00623	CbGpPWpGaD
Telaprevir—CTSK—Extracellular matrix organization—CASP3—peripheral nervous system neoplasm	5.05e-05	0.00621	CbGpPWpGaD
Telaprevir—CTSK—Immune System—NCAM1—peripheral nervous system neoplasm	4.96e-05	0.0061	CbGpPWpGaD
Telaprevir—CTSS—Immune System—CD34—peripheral nervous system neoplasm	4.8e-05	0.00591	CbGpPWpGaD
Telaprevir—ALB—Platelet degranulation—KNG1—peripheral nervous system neoplasm	4.66e-05	0.00573	CbGpPWpGaD
Telaprevir—CTSS—Immune System—PPP3R1—peripheral nervous system neoplasm	4.62e-05	0.00569	CbGpPWpGaD
Telaprevir—CYP3A4—Constitutive Androstane Receptor Pathway—ABCB1—peripheral nervous system neoplasm	4.49e-05	0.00553	CbGpPWpGaD
Telaprevir—ALB—Response to elevated platelet cytosolic Ca2+—KNG1—peripheral nervous system neoplasm	4.44e-05	0.00546	CbGpPWpGaD
Telaprevir—CMA1—Signaling Pathways—VIP—peripheral nervous system neoplasm	4.41e-05	0.00543	CbGpPWpGaD
Telaprevir—ABCB1—Integrated Pancreatic Cancer Pathway—NME1—peripheral nervous system neoplasm	4.34e-05	0.00534	CbGpPWpGaD
Telaprevir—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—peripheral nervous system neoplasm	4.28e-05	0.00527	CbGpPWpGaD
Telaprevir—CTSS—Extracellular matrix organization—CASP3—peripheral nervous system neoplasm	4.16e-05	0.00511	CbGpPWpGaD
Telaprevir—CTSS—Immune System—NCAM1—peripheral nervous system neoplasm	4.08e-05	0.00502	CbGpPWpGaD
Telaprevir—CMA1—Signaling Pathways—PPP3R1—peripheral nervous system neoplasm	4.07e-05	0.00501	CbGpPWpGaD
Telaprevir—CTSK—Immune System—IFNB1—peripheral nervous system neoplasm	3.89e-05	0.00479	CbGpPWpGaD
Telaprevir—ALB—Platelet degranulation—HGF—peripheral nervous system neoplasm	3.88e-05	0.00478	CbGpPWpGaD
Telaprevir—CTSK—Innate Immune System—PTPN11—peripheral nervous system neoplasm	3.76e-05	0.00463	CbGpPWpGaD
Telaprevir—ALB—Response to elevated platelet cytosolic Ca2+—HGF—peripheral nervous system neoplasm	3.7e-05	0.00455	CbGpPWpGaD
Telaprevir—CTSK—Adaptive Immune System—PTPN11—peripheral nervous system neoplasm	3.61e-05	0.00445	CbGpPWpGaD
Telaprevir—CTSS—Immune System—IFNB1—peripheral nervous system neoplasm	3.2e-05	0.00394	CbGpPWpGaD
Telaprevir—CTSS—Innate Immune System—PTPN11—peripheral nervous system neoplasm	3.1e-05	0.00381	CbGpPWpGaD
Telaprevir—CMA1—Signaling Pathways—NTRK2—peripheral nervous system neoplasm	3.06e-05	0.00376	CbGpPWpGaD
Telaprevir—CTSK—Immune System—HGF—peripheral nervous system neoplasm	3e-05	0.0037	CbGpPWpGaD
Telaprevir—ALB—Metabolism of lipids and lipoproteins—HSD17B12—peripheral nervous system neoplasm	2.99e-05	0.00367	CbGpPWpGaD
Telaprevir—CTSS—Adaptive Immune System—PTPN11—peripheral nervous system neoplasm	2.98e-05	0.00366	CbGpPWpGaD
Telaprevir—CTSK—Innate Immune System—ERBB2—peripheral nervous system neoplasm	2.97e-05	0.00366	CbGpPWpGaD
Telaprevir—CTSK—Adaptive Immune System—ERBB2—peripheral nervous system neoplasm	2.86e-05	0.00351	CbGpPWpGaD
Telaprevir—CMA1—Signaling Pathways—KNG1—peripheral nervous system neoplasm	2.62e-05	0.00322	CbGpPWpGaD
Telaprevir—CMA1—Signaling Pathways—NTRK1—peripheral nervous system neoplasm	2.49e-05	0.00307	CbGpPWpGaD
Telaprevir—CTSS—Immune System—HGF—peripheral nervous system neoplasm	2.47e-05	0.00304	CbGpPWpGaD
Telaprevir—CTSS—Innate Immune System—ERBB2—peripheral nervous system neoplasm	2.45e-05	0.00301	CbGpPWpGaD
Telaprevir—CTSS—Adaptive Immune System—ERBB2—peripheral nervous system neoplasm	2.35e-05	0.00289	CbGpPWpGaD
Telaprevir—CMA1—Signaling Pathways—GNAS—peripheral nervous system neoplasm	2.29e-05	0.00281	CbGpPWpGaD
Telaprevir—CTSK—Innate Immune System—NRAS—peripheral nervous system neoplasm	2.26e-05	0.00278	CbGpPWpGaD
Telaprevir—CTSK—Immune System—PTPN11—peripheral nervous system neoplasm	2.19e-05	0.0027	CbGpPWpGaD
Telaprevir—CTSK—Adaptive Immune System—NRAS—peripheral nervous system neoplasm	2.17e-05	0.00267	CbGpPWpGaD
Telaprevir—ABCB1—Integrated Pancreatic Cancer Pathway—CHEK2—peripheral nervous system neoplasm	2.13e-05	0.00262	CbGpPWpGaD
Telaprevir—ALB—Platelet activation, signaling and aggregation—KNG1—peripheral nervous system neoplasm	2.07e-05	0.00254	CbGpPWpGaD
Telaprevir—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—peripheral nervous system neoplasm	2.06e-05	0.00253	CbGpPWpGaD
Telaprevir—ALB—SLC-mediated transmembrane transport—SLC2A1—peripheral nervous system neoplasm	1.97e-05	0.00243	CbGpPWpGaD
Telaprevir—ALB—Metabolism—PPIP5K2—peripheral nervous system neoplasm	1.97e-05	0.00242	CbGpPWpGaD
Telaprevir—ABCB1—Integrated Pancreatic Cancer Pathway—NTRK1—peripheral nervous system neoplasm	1.94e-05	0.00239	CbGpPWpGaD
Telaprevir—ALB—Transmembrane transport of small molecules—COX2—peripheral nervous system neoplasm	1.89e-05	0.00233	CbGpPWpGaD
Telaprevir—CTSS—Innate Immune System—NRAS—peripheral nervous system neoplasm	1.86e-05	0.00229	CbGpPWpGaD
Telaprevir—CTSS—Immune System—PTPN11—peripheral nervous system neoplasm	1.81e-05	0.00222	CbGpPWpGaD
Telaprevir—ABCB1—Allograft Rejection—CASP3—peripheral nervous system neoplasm	1.8e-05	0.00221	CbGpPWpGaD
Telaprevir—CTSS—Adaptive Immune System—NRAS—peripheral nervous system neoplasm	1.79e-05	0.0022	CbGpPWpGaD
Telaprevir—ABCB1—Integrated Pancreatic Cancer Pathway—BDNF—peripheral nervous system neoplasm	1.78e-05	0.00219	CbGpPWpGaD
Telaprevir—ALB—FOXA2 and FOXA3 transcription factor networks—AKT1—peripheral nervous system neoplasm	1.77e-05	0.00218	CbGpPWpGaD
Telaprevir—CTSK—Immune System—ERBB2—peripheral nervous system neoplasm	1.73e-05	0.00213	CbGpPWpGaD
Telaprevir—ABCB1—Metabolism—PPIP5K2—peripheral nervous system neoplasm	1.73e-05	0.00212	CbGpPWpGaD
Telaprevir—ALB—Platelet activation, signaling and aggregation—HGF—peripheral nervous system neoplasm	1.72e-05	0.00212	CbGpPWpGaD
Telaprevir—ABCB1—Transmembrane transport of small molecules—COX2—peripheral nervous system neoplasm	1.66e-05	0.00204	CbGpPWpGaD
Telaprevir—CTSK—Innate Immune System—HRAS—peripheral nervous system neoplasm	1.66e-05	0.00204	CbGpPWpGaD
Telaprevir—CMA1—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	1.59e-05	0.00196	CbGpPWpGaD
Telaprevir—CTSK—Adaptive Immune System—HRAS—peripheral nervous system neoplasm	1.59e-05	0.00196	CbGpPWpGaD
Telaprevir—ALB—Folate Metabolism—TP53—peripheral nervous system neoplasm	1.52e-05	0.00187	CbGpPWpGaD
Telaprevir—CTSK—Innate Immune System—AKT1—peripheral nervous system neoplasm	1.46e-05	0.0018	CbGpPWpGaD
Telaprevir—CTSS—Immune System—ERBB2—peripheral nervous system neoplasm	1.43e-05	0.00176	CbGpPWpGaD
Telaprevir—CTSK—Adaptive Immune System—AKT1—peripheral nervous system neoplasm	1.4e-05	0.00173	CbGpPWpGaD
Telaprevir—CTSS—Innate Immune System—HRAS—peripheral nervous system neoplasm	1.36e-05	0.00168	CbGpPWpGaD
Telaprevir—ALB—Metabolism—HSD17B12—peripheral nervous system neoplasm	1.33e-05	0.00164	CbGpPWpGaD
Telaprevir—CTSK—Immune System—NRAS—peripheral nervous system neoplasm	1.32e-05	0.00162	CbGpPWpGaD
Telaprevir—CTSS—Adaptive Immune System—HRAS—peripheral nervous system neoplasm	1.31e-05	0.00161	CbGpPWpGaD
Telaprevir—CMA1—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	1.26e-05	0.00155	CbGpPWpGaD
Telaprevir—CTSS—Innate Immune System—AKT1—peripheral nervous system neoplasm	1.2e-05	0.00148	CbGpPWpGaD
Telaprevir—ABCB1—Metabolism—HSD17B12—peripheral nervous system neoplasm	1.17e-05	0.00143	CbGpPWpGaD
Telaprevir—CTSS—Adaptive Immune System—AKT1—peripheral nervous system neoplasm	1.16e-05	0.00142	CbGpPWpGaD
Telaprevir—ALB—Hemostasis—IFNB1—peripheral nervous system neoplasm	1.15e-05	0.00141	CbGpPWpGaD
Telaprevir—CMA1—Signaling Pathways—CASP3—peripheral nervous system neoplasm	1.14e-05	0.0014	CbGpPWpGaD
Telaprevir—ABCB1—HIF-1-alpha transcription factor network—AKT1—peripheral nervous system neoplasm	1.12e-05	0.00138	CbGpPWpGaD
Telaprevir—ALB—Metabolism of lipids and lipoproteins—BCHE—peripheral nervous system neoplasm	1.11e-05	0.00136	CbGpPWpGaD
Telaprevir—CTSS—Immune System—NRAS—peripheral nervous system neoplasm	1.09e-05	0.00134	CbGpPWpGaD
Telaprevir—ALB—Hemostasis—KNG1—peripheral nervous system neoplasm	1.07e-05	0.00131	CbGpPWpGaD
Telaprevir—CYP3A4—Metabolism—PPIP5K2—peripheral nervous system neoplasm	1.06e-05	0.00131	CbGpPWpGaD
Telaprevir—ALB—Transmembrane transport of small molecules—SLC2A1—peripheral nervous system neoplasm	1e-05	0.00123	CbGpPWpGaD
Telaprevir—ABCB1—Integrated Pancreatic Cancer Pathway—ERBB2—peripheral nervous system neoplasm	9.78e-06	0.0012	CbGpPWpGaD
Telaprevir—CTSK—Immune System—HRAS—peripheral nervous system neoplasm	9.64e-06	0.00119	CbGpPWpGaD
Telaprevir—ALB—Metabolism—GNS—peripheral nervous system neoplasm	9.62e-06	0.00118	CbGpPWpGaD
Telaprevir—CMA1—Signaling Pathways—NRAS—peripheral nervous system neoplasm	9.56e-06	0.00118	CbGpPWpGaD
Telaprevir—ALB—Hemostasis—GNAS—peripheral nervous system neoplasm	9.32e-06	0.00115	CbGpPWpGaD
Telaprevir—ALB—Metabolism—NME1—peripheral nervous system neoplasm	9.22e-06	0.00113	CbGpPWpGaD
Telaprevir—CMA1—Signaling Pathways—MYC—peripheral nervous system neoplasm	8.91e-06	0.0011	CbGpPWpGaD
Telaprevir—ALB—Hemostasis—HGF—peripheral nervous system neoplasm	8.88e-06	0.00109	CbGpPWpGaD
Telaprevir—ABCB1—Integrated Pancreatic Cancer Pathway—CASP3—peripheral nervous system neoplasm	8.87e-06	0.00109	CbGpPWpGaD
Telaprevir—ALB—Metabolism—COX2—peripheral nervous system neoplasm	8.87e-06	0.00109	CbGpPWpGaD
Telaprevir—ABCB1—Transmembrane transport of small molecules—SLC2A1—peripheral nervous system neoplasm	8.78e-06	0.00108	CbGpPWpGaD
Telaprevir—CTSK—Immune System—AKT1—peripheral nervous system neoplasm	8.51e-06	0.00105	CbGpPWpGaD
Telaprevir—ABCB1—Metabolism—GNS—peripheral nervous system neoplasm	8.43e-06	0.00104	CbGpPWpGaD
Telaprevir—ABCB1—Metabolism—NME1—peripheral nervous system neoplasm	8.08e-06	0.000994	CbGpPWpGaD
Telaprevir—ALB—Transmembrane transport of small molecules—GNAS—peripheral nervous system neoplasm	8.07e-06	0.000992	CbGpPWpGaD
Telaprevir—CTSS—Immune System—HRAS—peripheral nervous system neoplasm	7.94e-06	0.000977	CbGpPWpGaD
Telaprevir—ALB—Transmembrane transport of small molecules—ABCB1—peripheral nervous system neoplasm	7.92e-06	0.000974	CbGpPWpGaD
Telaprevir—ABCB1—Metabolism—COX2—peripheral nervous system neoplasm	7.78e-06	0.000957	CbGpPWpGaD
Telaprevir—CMA1—Signaling Pathways—TP53—peripheral nervous system neoplasm	7.31e-06	0.0009	CbGpPWpGaD
Telaprevir—CYP3A4—Metabolism—HSD17B12—peripheral nervous system neoplasm	7.18e-06	0.000883	CbGpPWpGaD
Telaprevir—ABCB1—Transmembrane transport of small molecules—GNAS—peripheral nervous system neoplasm	7.07e-06	0.00087	CbGpPWpGaD
Telaprevir—CTSS—Immune System—AKT1—peripheral nervous system neoplasm	7.01e-06	0.000863	CbGpPWpGaD
Telaprevir—CMA1—Signaling Pathways—HRAS—peripheral nervous system neoplasm	6.99e-06	0.000861	CbGpPWpGaD
Telaprevir—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—peripheral nervous system neoplasm	6.93e-06	0.000852	CbGpPWpGaD
Telaprevir—ALB—Hemostasis—PTPN11—peripheral nervous system neoplasm	6.48e-06	0.000797	CbGpPWpGaD
Telaprevir—CMA1—Signaling Pathways—AKT1—peripheral nervous system neoplasm	6.18e-06	0.00076	CbGpPWpGaD
Telaprevir—ALB—Metabolism—ENO2—peripheral nervous system neoplasm	5.83e-06	0.000717	CbGpPWpGaD
Telaprevir—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—peripheral nervous system neoplasm	5.69e-06	0.0007	CbGpPWpGaD
Telaprevir—CYP3A4—Metabolism—GNS—peripheral nervous system neoplasm	5.19e-06	0.000639	CbGpPWpGaD
Telaprevir—ABCB1—Metabolism—ENO2—peripheral nervous system neoplasm	5.1e-06	0.000628	CbGpPWpGaD
Telaprevir—CYP3A4—Metabolism—NME1—peripheral nervous system neoplasm	4.98e-06	0.000612	CbGpPWpGaD
Telaprevir—ALB—Metabolism—BCHE—peripheral nervous system neoplasm	4.92e-06	0.000606	CbGpPWpGaD
Telaprevir—ALB—Platelet activation, signaling and aggregation—AKT1—peripheral nervous system neoplasm	4.88e-06	0.0006	CbGpPWpGaD
Telaprevir—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—peripheral nervous system neoplasm	4.8e-06	0.000591	CbGpPWpGaD
Telaprevir—CYP3A4—Metabolism—COX2—peripheral nervous system neoplasm	4.79e-06	0.000589	CbGpPWpGaD
Telaprevir—ALB—Metabolism—SLC2A1—peripheral nervous system neoplasm	4.7e-06	0.000578	CbGpPWpGaD
Telaprevir—ALB—Metabolism—TH—peripheral nervous system neoplasm	4.63e-06	0.000569	CbGpPWpGaD
Telaprevir—ABCB1—Metabolism—BCHE—peripheral nervous system neoplasm	4.31e-06	0.000531	CbGpPWpGaD
Telaprevir—ABCB1—Metabolism—SLC2A1—peripheral nervous system neoplasm	4.11e-06	0.000506	CbGpPWpGaD
Telaprevir—ABCB1—Metabolism—TH—peripheral nervous system neoplasm	4.06e-06	0.000499	CbGpPWpGaD
Telaprevir—ALB—Hemostasis—NRAS—peripheral nervous system neoplasm	3.89e-06	0.000479	CbGpPWpGaD
Telaprevir—ALB—Metabolism—GNAS—peripheral nervous system neoplasm	3.78e-06	0.000465	CbGpPWpGaD
Telaprevir—ALB—Metabolism—ABCB1—peripheral nervous system neoplasm	3.71e-06	0.000456	CbGpPWpGaD
Telaprevir—ABCB1—Metabolism—GNAS—peripheral nervous system neoplasm	3.31e-06	0.000407	CbGpPWpGaD
Telaprevir—CYP3A4—Metabolism—ENO2—peripheral nervous system neoplasm	3.14e-06	0.000387	CbGpPWpGaD
Telaprevir—ALB—Hemostasis—TP53—peripheral nervous system neoplasm	2.98e-06	0.000366	CbGpPWpGaD
Telaprevir—ALB—Hemostasis—HRAS—peripheral nervous system neoplasm	2.85e-06	0.00035	CbGpPWpGaD
Telaprevir—CYP3A4—Metabolism—BCHE—peripheral nervous system neoplasm	2.66e-06	0.000327	CbGpPWpGaD
Telaprevir—CYP3A4—Metabolism—SLC2A1—peripheral nervous system neoplasm	2.53e-06	0.000312	CbGpPWpGaD
Telaprevir—ALB—Hemostasis—AKT1—peripheral nervous system neoplasm	2.52e-06	0.000309	CbGpPWpGaD
Telaprevir—CYP3A4—Metabolism—TH—peripheral nervous system neoplasm	2.5e-06	0.000307	CbGpPWpGaD
Telaprevir—CYP3A4—Metabolism—GNAS—peripheral nervous system neoplasm	2.04e-06	0.000251	CbGpPWpGaD
Telaprevir—CYP3A4—Metabolism—ABCB1—peripheral nervous system neoplasm	2e-06	0.000246	CbGpPWpGaD
Telaprevir—ALB—Metabolism—AKT1—peripheral nervous system neoplasm	1.02e-06	0.000125	CbGpPWpGaD
Telaprevir—ABCB1—Metabolism—AKT1—peripheral nervous system neoplasm	8.94e-07	0.00011	CbGpPWpGaD
Telaprevir—CYP3A4—Metabolism—AKT1—peripheral nervous system neoplasm	5.51e-07	6.77e-05	CbGpPWpGaD
